157 related articles for article (PubMed ID: 34397900)
1. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
Guo J; Min K; Deng L
Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Li H; Yan M; Wu X; Wang Y; Huang L
Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Xiao D; Xie J; Wu S
Medicine (Baltimore); 2021 Jun; 100(22):e25830. PubMed ID: 34087825
[TBL] [Abstract][Full Text] [Related]
4. Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Ding Y; Wu W; Ma Z; Shao X; Zhang M; Wang Z
Medicine (Baltimore); 2021 Jun; 100(22):e25964. PubMed ID: 34087839
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.
Wu L; Yin X; Jiang K; Yin J; Yu H; Yang L; Ma C; Yan S
Cancer Med; 2022 Apr; 11(7):1712-1731. PubMed ID: 35142083
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA as a biomarker for the prognosis of ischemic stroke: A protocol for meta-analysis and bioinformatics analysis.
Fu J; Yu Q; Xiao J; Li S
Medicine (Baltimore); 2021 Apr; 100(17):e25596. PubMed ID: 33907110
[TBL] [Abstract][Full Text] [Related]
7. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
Chen Z; Xiao Z; Zeng S; Yan Z
Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
[TBL] [Abstract][Full Text] [Related]
8. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
9. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA as a potential biomarker for prognosis of glioma: A protocol for systematic review and meta-analysis.
Xie T; Li B; Liu H; Zhang C; Wang Y; Chen Z; Yan J
Medicine (Baltimore); 2021 Aug; 100(33):e26921. PubMed ID: 34414948
[TBL] [Abstract][Full Text] [Related]
11. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
13. TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
Jin Z; Liu L; Yu Y; Li D; Zhu X; Yan D; Zhu Z
PLoS One; 2021; 16(9):e0257445. PubMed ID: 34534244
[TBL] [Abstract][Full Text] [Related]
14. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
15. The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
Zhang W; Wei L; Luo R; Liu H; Chen J
Medicine (Baltimore); 2020 Aug; 99(33):e21483. PubMed ID: 32871993
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Medicine (Baltimore); 2019 Nov; 98(48):e18024. PubMed ID: 31770215
[TBL] [Abstract][Full Text] [Related]
17. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis.
Xiao G; Yang Q; Bao Z; Mao H; Zhang Y; Lin S
BMC Cancer; 2020 Jun; 20(1):525. PubMed ID: 32503466
[TBL] [Abstract][Full Text] [Related]
18. The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
Liu L; Zhang X; Li C; Qu Y
Medicine (Baltimore); 2021 Aug; 100(32):e26923. PubMed ID: 34397935
[TBL] [Abstract][Full Text] [Related]
19. An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.
Geng B; Liang M; Qin L; Zhao W; Wang H; Wang L; Pan X; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1458-1469. PubMed ID: 30515965
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.
Ren Z; Li C; Gan Y; Liu X; Liang F
Medicine (Baltimore); 2021 Jun; 100(24):e26182. PubMed ID: 34128849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
